The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Certolizumab pegol can rapidly reduce the
inflammatory changes and inhibit erosions on hand and wrist MRI in patients with active
moderate to severe rheumatoid arthritis.
Phase:
Phase 3
Details
Lead Sponsor:
Oklahoma Medical Research Foundation
Collaborators:
Arthritis and Rheumatic Disease Specialties UCB Pharma